As a potential pathophysiological explanation, the upregulation of major histocompatibility complex (MHC)-II expression on MM cells, triggered by IFN-γ, may contribute to the dysregulated immune response within the pro-inflammatory microenvironment following CAR T-cell infusion (26). The gene discussed is IFNG; the disease is Miyoshi myopathy.